 Colleen Julian
Concepts (368)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Altitude | 50 | 2023 | 435 | 7.940 |
Why?
| | Pre-Eclampsia | 13 | 2023 | 166 | 3.450 |
Why?
| | Fetal Growth Retardation | 20 | 2023 | 470 | 3.240 |
Why?
| | Placenta | 10 | 2023 | 628 | 3.060 |
Why?
| | Hypoxia | 24 | 2023 | 956 | 3.040 |
Why?
| | Fetal Hypoxia | 7 | 2022 | 49 | 2.470 |
Why?
| | Altitude Sickness | 15 | 2022 | 170 | 2.450 |
Why?
| | Pregnancy | 53 | 2023 | 5499 | 2.170 |
Why?
| | Uterine Artery | 13 | 2022 | 67 | 2.100 |
Why?
| | Adaptation, Physiological | 12 | 2021 | 484 | 2.080 |
Why?
| | Acclimatization | 13 | 2019 | 147 | 1.920 |
Why?
| | PPAR gamma | 3 | 2020 | 182 | 1.610 |
Why?
| | Oxygen | 16 | 2023 | 851 | 1.520 |
Why?
| | Birth Weight | 12 | 2019 | 439 | 1.420 |
Why?
| | Placental Circulation | 6 | 2022 | 56 | 1.310 |
Why?
| | AMP-Activated Protein Kinases | 6 | 2023 | 170 | 1.130 |
Why?
| | Pregnancy Outcome | 4 | 2019 | 337 | 1.030 |
Why?
| | Vascular Endothelial Growth Factor Receptor-1 | 3 | 2022 | 68 | 1.020 |
Why?
| | Hypertension, Pregnancy-Induced | 5 | 2023 | 45 | 1.020 |
Why?
| | Selection, Genetic | 7 | 2019 | 237 | 1.010 |
Why?
| | Pregnancy Complications | 4 | 2017 | 430 | 0.990 |
Why?
| | Endothelin-1 | 2 | 2020 | 168 | 0.870 |
Why?
| | Biology | 1 | 2023 | 79 | 0.810 |
Why?
| | Uterus | 4 | 2020 | 191 | 0.790 |
Why?
| | Bolivia | 15 | 2023 | 62 | 0.760 |
Why?
| | Female | 67 | 2023 | 59324 | 0.750 |
Why?
| | Fetal Development | 7 | 2022 | 248 | 0.720 |
Why?
| | Hypertension, Pulmonary | 2 | 2022 | 1736 | 0.710 |
Why?
| | Mechanistic Target of Rapamycin Complex 1 | 1 | 2021 | 97 | 0.700 |
Why?
| | Sympathetic Nervous System | 6 | 2020 | 171 | 0.690 |
Why?
| | Neovascularization, Physiologic | 1 | 2021 | 174 | 0.650 |
Why?
| | Polycythemia | 3 | 2017 | 23 | 0.630 |
Why?
| | Erythropoietin | 3 | 2017 | 72 | 0.610 |
Why?
| | Pulmonary Circulation | 2 | 2021 | 407 | 0.580 |
Why?
| | Epigenesis, Genetic | 3 | 2023 | 518 | 0.570 |
Why?
| | Adult | 42 | 2021 | 30375 | 0.560 |
Why?
| | Vascular Diseases | 2 | 2017 | 233 | 0.550 |
Why?
| | Receptors, Erythropoietin | 1 | 2017 | 22 | 0.550 |
Why?
| | Humans | 73 | 2023 | 114045 | 0.550 |
Why?
| | Gene Expression Regulation | 3 | 2021 | 2322 | 0.510 |
Why?
| | Infant, Small for Gestational Age | 3 | 2011 | 75 | 0.510 |
Why?
| | Vascular Endothelial Growth Factor A | 3 | 2023 | 496 | 0.490 |
Why?
| | Regional Blood Flow | 7 | 2015 | 421 | 0.490 |
Why?
| | Enzymes | 2 | 2013 | 62 | 0.480 |
Why?
| | Arteries | 3 | 2022 | 246 | 0.470 |
Why?
| | Vasodilation | 4 | 2022 | 418 | 0.470 |
Why?
| | Prenatal Exposure Delayed Effects | 2 | 2021 | 453 | 0.470 |
Why?
| | DNA Methylation | 2 | 2023 | 493 | 0.420 |
Why?
| | Sleep Apnea Syndromes | 1 | 2013 | 74 | 0.390 |
Why?
| | Erythrocytes | 4 | 2017 | 568 | 0.390 |
Why?
| | Signal Transduction | 3 | 2021 | 4501 | 0.390 |
Why?
| | Blood Proteins | 1 | 2013 | 222 | 0.390 |
Why?
| | Antioxidants | 2 | 2013 | 529 | 0.380 |
Why?
| | Hemoglobins | 7 | 2017 | 308 | 0.380 |
Why?
| | Oxygen Consumption | 2 | 2011 | 587 | 0.380 |
Why?
| | Case-Control Studies | 8 | 2017 | 3003 | 0.380 |
Why?
| | Infant, Low Birth Weight | 2 | 2011 | 124 | 0.370 |
Why?
| | Infant, Newborn | 12 | 2022 | 5038 | 0.370 |
Why?
| | Cell Membrane Permeability | 1 | 2011 | 83 | 0.370 |
Why?
| | Biological Evolution | 2 | 2015 | 406 | 0.350 |
Why?
| | Oxidative Stress | 2 | 2013 | 1068 | 0.350 |
Why?
| | Erythropoiesis | 2 | 2014 | 33 | 0.340 |
Why?
| | Placental Insufficiency | 2 | 2023 | 102 | 0.340 |
Why?
| | Gestational Age | 9 | 2021 | 761 | 0.330 |
Why?
| | Young Adult | 18 | 2020 | 10444 | 0.330 |
Why?
| | Polymorphism, Single Nucleotide | 8 | 2019 | 1880 | 0.330 |
Why?
| | Lung Diseases | 1 | 2015 | 690 | 0.320 |
Why?
| | Women's Health | 1 | 2011 | 270 | 0.320 |
Why?
| | Fertility | 1 | 2009 | 128 | 0.310 |
Why?
| | Lung | 1 | 2021 | 3521 | 0.310 |
Why?
| | Proteomics | 1 | 2013 | 815 | 0.300 |
Why?
| | Hypertension | 1 | 2015 | 1052 | 0.290 |
Why?
| | Hemodynamics | 3 | 2021 | 1015 | 0.290 |
Why?
| | Cerebrovascular Circulation | 3 | 2013 | 219 | 0.270 |
Why?
| | Receptor, Adenosine A2B | 2 | 2017 | 32 | 0.270 |
Why?
| | Disease Models, Animal | 3 | 2021 | 3498 | 0.270 |
Why?
| | Maternal-Fetal Exchange | 2 | 2021 | 151 | 0.260 |
Why?
| | Nitric Oxide | 2 | 2020 | 817 | 0.240 |
Why?
| | Animals | 12 | 2023 | 31565 | 0.240 |
Why?
| | Mice, Inbred C57BL | 5 | 2021 | 4680 | 0.230 |
Why?
| | Blood Pressure | 7 | 2020 | 1531 | 0.230 |
Why?
| | Placenta Growth Factor | 2 | 2022 | 23 | 0.220 |
Why?
| | HELLP Syndrome | 1 | 2023 | 6 | 0.220 |
Why?
| | Physical Education and Training | 1 | 2003 | 62 | 0.220 |
Why?
| | Muscle, Skeletal | 5 | 2023 | 1468 | 0.220 |
Why?
| | Mice | 7 | 2021 | 14843 | 0.220 |
Why?
| | Male | 19 | 2019 | 55396 | 0.220 |
Why?
| | Phenotype | 2 | 2023 | 2784 | 0.210 |
Why?
| | Phenylephrine | 2 | 2020 | 71 | 0.210 |
Why?
| | Amino Acids | 3 | 2023 | 445 | 0.210 |
Why?
| | Longitudinal Studies | 3 | 2019 | 2384 | 0.210 |
Why?
| | Ion Channels | 1 | 2023 | 121 | 0.210 |
Why?
| | Task Performance and Analysis | 1 | 2003 | 160 | 0.210 |
Why?
| | Baroreflex | 3 | 2020 | 54 | 0.200 |
Why?
| | Geography | 3 | 2011 | 176 | 0.200 |
Why?
| | Vascular Endothelial Growth Factors | 1 | 2022 | 61 | 0.200 |
Why?
| | Cesarean Section | 1 | 2023 | 169 | 0.200 |
Why?
| | Biomarkers | 4 | 2017 | 3397 | 0.200 |
Why?
| | Cross-Sectional Studies | 4 | 2022 | 4402 | 0.190 |
Why?
| | Acute Disease | 3 | 2013 | 907 | 0.190 |
Why?
| | Arterial Pressure | 3 | 2020 | 99 | 0.190 |
Why?
| | Running | 1 | 2003 | 207 | 0.190 |
Why?
| | Acetazolamide | 2 | 2011 | 30 | 0.190 |
Why?
| | Phosphorylation | 3 | 2021 | 1558 | 0.180 |
Why?
| | Frailty | 1 | 2023 | 113 | 0.180 |
Why?
| | Pedigree | 2 | 2020 | 460 | 0.180 |
Why?
| | Ventricular Pressure | 1 | 2021 | 39 | 0.180 |
Why?
| | Inflammation | 1 | 2011 | 2464 | 0.180 |
Why?
| | Hyperbaric Oxygenation | 1 | 2021 | 36 | 0.180 |
Why?
| | Mammals | 1 | 2022 | 241 | 0.180 |
Why?
| | Genomics | 2 | 2023 | 631 | 0.180 |
Why?
| | Blood Volume | 3 | 2017 | 57 | 0.180 |
Why?
| | Europe | 4 | 2009 | 332 | 0.170 |
Why?
| | Pregnancy-Associated Plasma Protein-A | 1 | 2020 | 14 | 0.170 |
Why?
| | Myometrium | 1 | 2020 | 35 | 0.170 |
Why?
| | Abortion, Spontaneous | 1 | 2020 | 89 | 0.170 |
Why?
| | Geographic Mapping | 1 | 2019 | 20 | 0.170 |
Why?
| | Pulmonary Artery | 2 | 2015 | 1024 | 0.170 |
Why?
| | Vascular Resistance | 4 | 2020 | 340 | 0.170 |
Why?
| | Hypoxia-Inducible Factor-Proline Dioxygenases | 2 | 2017 | 20 | 0.160 |
Why?
| | Dexamethasone | 2 | 2011 | 316 | 0.160 |
Why?
| | Thiazolidinediones | 1 | 2020 | 142 | 0.160 |
Why?
| | Ventricular Function, Right | 1 | 2021 | 256 | 0.160 |
Why?
| | Genetics, Population | 2 | 2010 | 187 | 0.160 |
Why?
| | Nitric Oxide Synthase | 1 | 2019 | 209 | 0.150 |
Why?
| | Adenosine | 2 | 2017 | 203 | 0.150 |
Why?
| | Gene Expression | 1 | 2023 | 1417 | 0.150 |
Why?
| | Fetus | 3 | 2023 | 698 | 0.150 |
Why?
| | Protein Kinases | 1 | 2020 | 304 | 0.150 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2021 | 367 | 0.150 |
Why?
| | Trophoblasts | 1 | 2019 | 165 | 0.150 |
Why?
| | Time Factors | 5 | 2017 | 6077 | 0.150 |
Why?
| | Maternal Health Services | 1 | 2019 | 79 | 0.150 |
Why?
| | Peroneal Nerve | 1 | 2017 | 19 | 0.150 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 2 | 2017 | 225 | 0.140 |
Why?
| | Equilibrative Nucleoside Transporter 1 | 1 | 2017 | 13 | 0.140 |
Why?
| | Cell Cycle Proteins | 1 | 2021 | 549 | 0.140 |
Why?
| | Middle Cerebral Artery | 2 | 2013 | 36 | 0.140 |
Why?
| | Colorado | 3 | 2019 | 4090 | 0.140 |
Why?
| | Heart Rate | 5 | 2020 | 710 | 0.140 |
Why?
| | Epigenomics | 1 | 2017 | 98 | 0.140 |
Why?
| | Muscle, Smooth, Vascular | 1 | 2019 | 409 | 0.130 |
Why?
| | Sphingosine | 1 | 2016 | 33 | 0.130 |
Why?
| | Cardiovascular System | 1 | 2017 | 126 | 0.130 |
Why?
| | Lysophospholipids | 1 | 2016 | 65 | 0.130 |
Why?
| | Double-Blind Method | 3 | 2011 | 1656 | 0.130 |
Why?
| | Autonomic Pathways | 1 | 2015 | 2 | 0.130 |
Why?
| | Immunohistochemistry | 1 | 2020 | 1624 | 0.130 |
Why?
| | California | 1 | 2017 | 351 | 0.130 |
Why?
| | Pulmonary Gas Exchange | 1 | 2015 | 117 | 0.120 |
Why?
| | Pulmonary Veins | 1 | 2015 | 83 | 0.120 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 787 | 0.120 |
Why?
| | Diabetes, Gestational | 1 | 2018 | 281 | 0.120 |
Why?
| | Receptor, Endothelin A | 1 | 2014 | 60 | 0.110 |
Why?
| | Muscles | 1 | 2015 | 320 | 0.110 |
Why?
| | Incidence | 2 | 2018 | 2314 | 0.110 |
Why?
| | Aromatase | 1 | 2014 | 30 | 0.110 |
Why?
| | Prospective Studies | 3 | 2022 | 6195 | 0.110 |
Why?
| | Biological Transport | 2 | 2019 | 374 | 0.110 |
Why?
| | Homeostasis | 2 | 2014 | 570 | 0.110 |
Why?
| | Parity | 3 | 2018 | 97 | 0.110 |
Why?
| | Tibet | 4 | 2017 | 28 | 0.110 |
Why?
| | Congenital Abnormalities | 2 | 1991 | 72 | 0.110 |
Why?
| | Leukocytes, Mononuclear | 1 | 2015 | 489 | 0.110 |
Why?
| | Endothelium, Vascular | 1 | 2019 | 830 | 0.100 |
Why?
| | Glycolysis | 3 | 2021 | 224 | 0.100 |
Why?
| | Ultrasonography, Doppler | 3 | 2020 | 104 | 0.100 |
Why?
| | Health Services Accessibility | 1 | 2019 | 756 | 0.100 |
Why?
| | Delivery, Obstetric | 2 | 2011 | 118 | 0.100 |
Why?
| | Risk Factors | 6 | 2019 | 8614 | 0.100 |
Why?
| | Body Height | 1 | 2013 | 180 | 0.100 |
Why?
| | Regression Analysis | 3 | 2018 | 945 | 0.100 |
Why?
| | Polysomnography | 1 | 2013 | 136 | 0.100 |
Why?
| | Prenatal Diagnosis | 2 | 1991 | 163 | 0.100 |
Why?
| | Healthy Volunteers | 3 | 2017 | 191 | 0.100 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2013 | 465 | 0.100 |
Why?
| | Carbonic Anhydrase Inhibitors | 1 | 2011 | 17 | 0.090 |
Why?
| | Estrogens | 1 | 2014 | 312 | 0.090 |
Why?
| | Apgar Score | 1 | 2011 | 16 | 0.090 |
Why?
| | Tandem Mass Spectrometry | 1 | 2013 | 410 | 0.090 |
Why?
| | Hypoxia, Brain | 1 | 2011 | 10 | 0.090 |
Why?
| | Respiratory Function Tests | 1 | 2013 | 522 | 0.090 |
Why?
| | Mountaineering | 1 | 2011 | 45 | 0.090 |
Why?
| | Follow-Up Studies | 2 | 2017 | 4392 | 0.090 |
Why?
| | Respiratory Physiological Phenomena | 1 | 2011 | 29 | 0.090 |
Why?
| | Brain Edema | 1 | 2011 | 59 | 0.090 |
Why?
| | Retrospective Studies | 4 | 2022 | 12521 | 0.090 |
Why?
| | Lactic Acid | 2 | 2023 | 272 | 0.090 |
Why?
| | Angiostatic Proteins | 1 | 2010 | 5 | 0.090 |
Why?
| | Oxidation-Reduction | 1 | 2013 | 917 | 0.090 |
Why?
| | Blood-Brain Barrier | 1 | 2011 | 106 | 0.090 |
Why?
| | Angiogenic Proteins | 1 | 2010 | 17 | 0.090 |
Why?
| | Confidence Intervals | 1 | 2011 | 302 | 0.090 |
Why?
| | Headache | 1 | 2011 | 132 | 0.090 |
Why?
| | Sheep | 2 | 2023 | 761 | 0.080 |
Why?
| | Cohort Studies | 3 | 2020 | 4883 | 0.080 |
Why?
| | Anthropology, Physical | 1 | 2009 | 27 | 0.080 |
Why?
| | Fetal Diseases | 1 | 1991 | 146 | 0.080 |
Why?
| | HIV Infections | 1 | 2023 | 2453 | 0.080 |
Why?
| | Databases, Genetic | 1 | 2010 | 206 | 0.080 |
Why?
| | Fetal Blood | 1 | 2011 | 268 | 0.080 |
Why?
| | Prognosis | 1 | 2017 | 3315 | 0.080 |
Why?
| | Up-Regulation | 1 | 2011 | 802 | 0.080 |
Why?
| | Adolescent | 3 | 2019 | 17800 | 0.080 |
Why?
| | South America | 3 | 2014 | 52 | 0.080 |
Why?
| | Genome, Human | 1 | 2010 | 347 | 0.080 |
Why?
| | Interleukin-1beta | 1 | 2010 | 368 | 0.080 |
Why?
| | Chronic Disease | 1 | 2013 | 1577 | 0.070 |
Why?
| | Anti-Inflammatory Agents | 1 | 2011 | 445 | 0.070 |
Why?
| | Head | 1 | 2008 | 85 | 0.070 |
Why?
| | Femur | 1 | 2008 | 191 | 0.070 |
Why?
| | Urban Health | 1 | 2007 | 73 | 0.070 |
Why?
| | Rest | 2 | 2019 | 103 | 0.070 |
Why?
| | Health Status | 1 | 2011 | 716 | 0.070 |
Why?
| | GPI-Linked Proteins | 2 | 2017 | 54 | 0.070 |
Why?
| | 5'-Nucleotidase | 2 | 2017 | 35 | 0.070 |
Why?
| | 2,3-Diphosphoglycerate | 2 | 2016 | 28 | 0.070 |
Why?
| | Pregnancy Complications, Cardiovascular | 1 | 2007 | 64 | 0.070 |
Why?
| | Indians, South American | 3 | 2013 | 22 | 0.070 |
Why?
| | Ultrasonography, Prenatal | 3 | 2013 | 237 | 0.060 |
Why?
| | Blood Flow Velocity | 3 | 2013 | 388 | 0.060 |
Why?
| | Down Syndrome | 1 | 1991 | 335 | 0.060 |
Why?
| | Cold Temperature | 2 | 2017 | 125 | 0.060 |
Why?
| | Respiratory Distress Syndrome, Newborn | 1 | 2007 | 101 | 0.060 |
Why?
| | Mental Health | 1 | 2011 | 559 | 0.060 |
Why?
| | Haplotypes | 2 | 2017 | 448 | 0.060 |
Why?
| | Maternal Age | 2 | 2018 | 116 | 0.060 |
Why?
| | Indians, North American | 1 | 2009 | 564 | 0.060 |
Why?
| | Reticulocyte Count | 1 | 2003 | 5 | 0.060 |
Why?
| | Age Factors | 1 | 2011 | 2885 | 0.060 |
Why?
| | Gene Expression Profiling | 1 | 2010 | 1518 | 0.060 |
Why?
| | Surveys and Questionnaires | 3 | 2013 | 4595 | 0.060 |
Why?
| | Receptors, Transferrin | 1 | 2003 | 22 | 0.060 |
Why?
| | Chi-Square Distribution | 2 | 2018 | 492 | 0.060 |
Why?
| | Pyruvates | 1 | 2023 | 20 | 0.050 |
Why?
| | Solubility | 1 | 2003 | 223 | 0.050 |
Why?
| | Cytokines | 1 | 2010 | 1824 | 0.050 |
Why?
| | Glutamine | 1 | 2023 | 91 | 0.050 |
Why?
| | Body Weight | 1 | 2007 | 868 | 0.050 |
Why?
| | Serine | 1 | 2023 | 125 | 0.050 |
Why?
| | Glycine | 1 | 2023 | 152 | 0.050 |
Why?
| | Developing Countries | 1 | 2023 | 231 | 0.050 |
Why?
| | Potassium Channels | 1 | 2022 | 121 | 0.050 |
Why?
| | Gene Frequency | 2 | 2014 | 476 | 0.050 |
Why?
| | Pyruvic Acid | 1 | 2021 | 42 | 0.050 |
Why?
| | Blood Gas Analysis | 2 | 2014 | 70 | 0.050 |
Why?
| | Amniocentesis | 2 | 1991 | 21 | 0.040 |
Why?
| | Pregnancy Trimester, Third | 2 | 2019 | 79 | 0.040 |
Why?
| | Aminoimidazole Carboxamide | 1 | 2020 | 10 | 0.040 |
Why?
| | Pyrones | 1 | 2020 | 9 | 0.040 |
Why?
| | Mice, Knockout | 2 | 2017 | 2562 | 0.040 |
Why?
| | Adenosine Triphosphate | 1 | 2022 | 428 | 0.040 |
Why?
| | Ribonucleotides | 1 | 2020 | 24 | 0.040 |
Why?
| | Biphenyl Compounds | 1 | 2020 | 50 | 0.040 |
Why?
| | Thiophenes | 1 | 2020 | 108 | 0.040 |
Why?
| | Vasoconstrictor Agents | 1 | 2020 | 113 | 0.040 |
Why?
| | Acetylcholine | 1 | 2020 | 166 | 0.040 |
Why?
| | Ultrasonography | 2 | 2014 | 635 | 0.040 |
Why?
| | Glucose | 1 | 2023 | 899 | 0.040 |
Why?
| | Vasodilator Agents | 1 | 2020 | 302 | 0.040 |
Why?
| | Genome-Wide Association Study | 2 | 2017 | 1176 | 0.040 |
Why?
| | Genotype | 2 | 2014 | 1757 | 0.040 |
Why?
| | Evoked Potentials, Motor | 1 | 2017 | 34 | 0.040 |
Why?
| | Renin | 1 | 2017 | 31 | 0.040 |
Why?
| | Arginine Vasopressin | 1 | 2017 | 46 | 0.040 |
Why?
| | Recruitment, Neurophysiological | 1 | 2017 | 35 | 0.040 |
Why?
| | Aldosterone | 1 | 2017 | 42 | 0.040 |
Why?
| | Osmolar Concentration | 1 | 2017 | 169 | 0.040 |
Why?
| | Ferritins | 1 | 2017 | 52 | 0.030 |
Why?
| | Ubiquitination | 1 | 2017 | 86 | 0.030 |
Why?
| | Bisphosphoglycerate Mutase | 1 | 2016 | 7 | 0.030 |
Why?
| | Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating) | 1 | 2016 | 6 | 0.030 |
Why?
| | Pentose Phosphate Pathway | 1 | 2016 | 47 | 0.030 |
Why?
| | Phosphotransferases (Alcohol Group Acceptor) | 1 | 2016 | 41 | 0.030 |
Why?
| | Posture | 1 | 2017 | 152 | 0.030 |
Why?
| | Sulfur | 1 | 2016 | 46 | 0.030 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 1 | 2017 | 130 | 0.030 |
Why?
| | Mice, Mutant Strains | 1 | 2016 | 271 | 0.030 |
Why?
| | Purines | 1 | 2016 | 158 | 0.030 |
Why?
| | Gene-Environment Interaction | 1 | 2017 | 182 | 0.030 |
Why?
| | Arginine | 1 | 2016 | 236 | 0.030 |
Why?
| | Glutathione | 1 | 2016 | 293 | 0.030 |
Why?
| | Diastole | 1 | 2015 | 137 | 0.030 |
Why?
| | Vagus Nerve | 1 | 2015 | 79 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2018 | 1422 | 0.030 |
Why?
| | Action Potentials | 1 | 2017 | 406 | 0.030 |
Why?
| | Infant | 2 | 2020 | 7943 | 0.030 |
Why?
| | Enzyme Activation | 1 | 2016 | 771 | 0.030 |
Why?
| | Receptor, Endothelin B | 1 | 2014 | 51 | 0.030 |
Why?
| | Receptors, Endothelin | 1 | 2014 | 49 | 0.030 |
Why?
| | Protein Processing, Post-Translational | 1 | 2016 | 399 | 0.030 |
Why?
| | Aging | 1 | 2023 | 1611 | 0.030 |
Why?
| | Ultrasonography, Doppler, Transcranial | 1 | 2013 | 42 | 0.030 |
Why?
| | Evaluation Studies as Topic | 2 | 1991 | 167 | 0.030 |
Why?
| | Metabolome | 1 | 2016 | 274 | 0.030 |
Why?
| | Body Weights and Measures | 1 | 2013 | 33 | 0.030 |
Why?
| | Exercise | 1 | 2023 | 1642 | 0.030 |
Why?
| | Radial Artery | 1 | 2013 | 66 | 0.030 |
Why?
| | Acute Lung Injury | 1 | 2016 | 268 | 0.030 |
Why?
| | Aged | 2 | 2023 | 18969 | 0.030 |
Why?
| | Gonadal Steroid Hormones | 1 | 2014 | 123 | 0.030 |
Why?
| | Gene Regulatory Networks | 1 | 2014 | 229 | 0.030 |
Why?
| | Prevalence | 1 | 2018 | 2247 | 0.030 |
Why?
| | Genetic Association Studies | 1 | 2014 | 339 | 0.030 |
Why?
| | Child | 1 | 2011 | 18401 | 0.020 |
Why?
| | Linear Models | 1 | 2014 | 768 | 0.020 |
Why?
| | Obstetric Labor, Premature | 1 | 1992 | 33 | 0.020 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2014 | 359 | 0.020 |
Why?
| | Exercise Test | 1 | 2014 | 547 | 0.020 |
Why?
| | Pregnancy, High-Risk | 1 | 1991 | 12 | 0.020 |
Why?
| | Live Birth | 1 | 2011 | 47 | 0.020 |
Why?
| | Laser-Doppler Flowmetry | 1 | 2011 | 32 | 0.020 |
Why?
| | Iliac Artery | 1 | 2011 | 44 | 0.020 |
Why?
| | Globins | 1 | 2010 | 21 | 0.020 |
Why?
| | Procollagen-Proline Dioxygenase | 1 | 2010 | 26 | 0.020 |
Why?
| | Stillbirth | 1 | 2011 | 57 | 0.020 |
Why?
| | Pregnancy Proteins | 1 | 2010 | 36 | 0.020 |
Why?
| | Renin-Angiotensin System | 1 | 2010 | 72 | 0.020 |
Why?
| | Interleukin-4 | 1 | 2010 | 204 | 0.020 |
Why?
| | DNA Copy Number Variations | 1 | 2010 | 153 | 0.020 |
Why?
| | Prenatal Care | 1 | 1992 | 250 | 0.020 |
Why?
| | Interleukin 1 Receptor Antagonist Protein | 1 | 2010 | 253 | 0.020 |
Why?
| | Cross-Over Studies | 1 | 2011 | 439 | 0.020 |
Why?
| | Anticonvulsants | 1 | 2011 | 178 | 0.020 |
Why?
| | Pregnant Women | 1 | 1990 | 129 | 0.020 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2010 | 250 | 0.020 |
Why?
| | Middle Aged | 2 | 2019 | 26605 | 0.020 |
Why?
| | Interleukin-10 | 1 | 2010 | 293 | 0.020 |
Why?
| | Transcription, Genetic | 1 | 2014 | 1310 | 0.020 |
Why?
| | Insurance, Health | 1 | 1990 | 243 | 0.020 |
Why?
| | Infant, Premature | 1 | 1992 | 478 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2011 | 1218 | 0.020 |
Why?
| | Models, Biological | 1 | 2015 | 1611 | 0.020 |
Why?
| | Premature Birth | 1 | 2011 | 275 | 0.020 |
Why?
| | Heart Rate, Fetal | 1 | 2007 | 20 | 0.020 |
Why?
| | Respiratory Mechanics | 1 | 2007 | 56 | 0.020 |
Why?
| | Biometry | 1 | 2007 | 62 | 0.020 |
Why?
| | Phylogeny | 1 | 2010 | 787 | 0.020 |
Why?
| | Cognition | 1 | 2014 | 990 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2017 | 6306 | 0.020 |
Why?
| | Interleukin-6 | 1 | 2010 | 673 | 0.020 |
Why?
| | Patient Selection | 1 | 1990 | 629 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 1991 | 1690 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2013 | 2537 | 0.020 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2010 | 1128 | 0.020 |
Why?
| | Heart Failure | 1 | 2017 | 1958 | 0.010 |
Why?
| | Patient Acceptance of Health Care | 1 | 1990 | 675 | 0.010 |
Why?
| | Lower Extremity | 1 | 2007 | 334 | 0.010 |
Why?
| | Genetic Predisposition to Disease | 1 | 2010 | 2090 | 0.010 |
Why?
| | Risk Assessment | 1 | 2010 | 2958 | 0.010 |
Why?
| | France | 2 | 1992 | 28 | 0.010 |
Why?
| | Educational Status | 2 | 1992 | 408 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2011 | 9049 | 0.010 |
Why?
| | Hospitals, Maternity | 1 | 1992 | 4 | 0.010 |
Why?
| | Fathers | 1 | 1992 | 43 | 0.010 |
Why?
| | Marriage | 1 | 1992 | 105 | 0.010 |
Why?
| | Occupations | 1 | 1990 | 35 | 0.010 |
Why?
| | Resource Allocation | 1 | 1990 | 37 | 0.010 |
Why?
| | Chromosome Disorders | 1 | 1990 | 35 | 0.010 |
Why?
| | Social Values | 1 | 1990 | 36 | 0.010 |
Why?
| | Personal Autonomy | 1 | 1990 | 39 | 0.010 |
Why?
| | Chromosome Aberrations | 1 | 1990 | 134 | 0.010 |
Why?
| | Religion | 1 | 1990 | 64 | 0.010 |
Why?
| | Culture | 1 | 1990 | 122 | 0.010 |
Why?
| | Pregnancy Trimester, Second | 1 | 1989 | 66 | 0.000 |
Why?
| | Social Class | 1 | 1990 | 205 | 0.000 |
Why?
| | Risk | 1 | 1990 | 810 | 0.000 |
Why?
| | Smoking | 1 | 1992 | 1382 | 0.000 |
Why?
|
|
Julian's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|